Mapping SARS-CoV-2 antigenic relationships and serological responses
Wilks, Samuel H.; Mühlemann, Barbara; Shen, Xiaoying; Türeli, Sina; LeGresley, Eric B.; Netzl, Antonia; Caniza, Miguela A.; Chacaltana-Huarcaya, Jesus N.; Corman, Victor M.; Daniell, Xiaoju; Datto, Michael B.; Dawood, Fatimah S.; Denny, Thomas N.; Drosten, Christian; Fouchier, Ron A. M.; Garcia Funegra, Patricia Jannet; Halfmann, Peter J.; Jassem, Agatha; Jeworowski, Lara M.; Jones, Terry C.; Kawaoka, Yoshihiro; Krammer, Florian; McDanal, Charlene; Pajon, Rolando; Simon, Viviana; Stockwell, Melissa S.; Tang, Haili; van Bakel, Harm; Veguilla, Vic; Webby, Richard; Montefiori, David C.; Smith, Derek J.
Fecha:
2023
Resumen:
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)–1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.
Mostrar el registro completo del ítem